Please provide your email address to receive an email when new articles are posted on . Use of vaginal estrogen therapy does not affect recurrence risk for women previously diagnosed with endometrial ...

Women who use vaginal estrogen to manage early menopause after treatment for endometrial cancer may not have an increased risk for recurrence.

Despite the increased incidence of endometrial cancer in younger women, there is limited research regarding the safety of local, low-dose vaginal estrogen therapy (ET) for survivors. A new study ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Gini F. Fleming, ...

—A new study from California-based researchers reports that things may be getting worse for certain women at risk for endometrial cancer. Here’s what the research team adds to what’s known about ...

Among women with endometrial intraepithelial neoplasia, hysteroscopy-directed sampling of the endometrium has been shown to increase the odds of detecting a concurrent endometrial malignancy, a new ...

Acrivon Therapeutics (NASDAQ:ACRV) hosted a webcast featuring a key opinion leader (KOL) panel focused on the company’s ...

Add Yahoo as a preferred source to see more of our stories on Google. “Uterine cancer is a cancer that starts in the uterus, the ‘womb’ or organ where a pregnancy grows,” says Vincent Wagner, MD, ...

Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

"I wasn’t reading the signs... I thought, ‘This is what it’s like to be in your 60s, and it’s just part and parcel of getting older,' " Kingston recalled ...